22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here

  • Home
  • About Us
    • Our Company
    • Our Leadership Team
    • Board of Directors
  • Reduced Nicotine Tobacco
    • VLN®
    • Clinical Studies & Commentaries
  • Hemp/Cannabis Innovation
    • GVB Biopharma
  • Hops Research
  • News
  • Investors
    • Overview
    • New Investor / Latest Resources
    • Events
    • News
    • Stock Data
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
    • Annual Reports
    • FAQs
  • Contact Us

Annual Reports

Investors

Investors

  • Overview
  • New Investor / Latest Resources
  • Events
  • News
    • Press Releases
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Trades
  • SEC Filings
  • Analyst Coverage
  • Corporate Governance
  • Annual Reports
  • FAQs
2021 Annual Report

2021 Annual Report

2020 Annual Report

2020 Annual Report

2019 Annual Report

2019 Annual Report

2018 Annual Report

2018 Annual Report

2017 Annual Report

2017 Annual Report

2016 Annual Report

2016 Annual Report

2015 Annual Report

2015 Annual Report

2014 Annual Report

2014 Annual Report

2013 Annual Report

2013 Annual Report

2012 Annual Report

2012 Annual Report

RSS
  • Email Alerts
  • Contact
  • RSS News Feed
© 2023 22nd Century Group, Inc. All Rights Reserved.
Privacy Policy / CCPA Disclaimer Sitemap